Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 8346 | 1193 | 38.1 | 64% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 469 | 15101 | BRONCHOPULMONARY DYSPLASIA//PULMONARY SURFACTANT//RESPIRATORY DISTRESS SYNDROME |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | OXYGEN TOXICITY | Author keyword | 10 | 17% | 4% | 52 |
| 2 | WINTHROP UNIV HOSP | Address | 5 | 22% | 2% | 21 |
| 3 | HYPEROXIC LUNG INJURY | Author keyword | 5 | 41% | 1% | 9 |
| 4 | IMMUNOL BONE MARROW TRANSPLANT PROGRAM | Address | 3 | 100% | 0% | 3 |
| 5 | FETAL TYPE II CELLS | Author keyword | 2 | 67% | 0% | 2 |
| 6 | RECOMBINANT HUMAN SUPEROXIDE DISMUTASE | Author keyword | 2 | 67% | 0% | 2 |
| 7 | HYPOX STATES | Address | 1 | 38% | 0% | 3 |
| 8 | PULMONARY OXYGEN TOXICITY | Author keyword | 1 | 21% | 1% | 6 |
| 9 | TERMINAL DEOXYNUCLEOTIDYLTRANSFERASE MEDIATED DUTP NICK END LABELING | Author keyword | 1 | 100% | 0% | 2 |
| 10 | HYPEROXIC INJURY | Author keyword | 1 | 40% | 0% | 2 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | PULMONARY OXYGEN TOXICITY | 79 | 50% | 9% | 113 |
| 2 | OXYGEN TOXICITY | 50 | 24% | 15% | 180 |
| 3 | O 2 TOXICITY | 18 | 89% | 1% | 8 |
| 4 | PRETERM GUINEA PIG | 9 | 83% | 0% | 5 |
| 5 | NEUTROPENIC RABBITS | 9 | 67% | 1% | 8 |
| 6 | PERINATAL RAT LUNG | 8 | 100% | 0% | 5 |
| 7 | PROTECTS RATS | 6 | 31% | 1% | 17 |
| 8 | PULMONARY SUPEROXIDE DISMUTASE | 6 | 71% | 0% | 5 |
| 9 | CATALASE MESSENGER RNA | 4 | 75% | 0% | 3 |
| 10 | MEDIATED AUGMENTATION | 3 | 50% | 0% | 5 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| Molecular mechanisms of hyperoxia-induced acute lung injury | 2008 | 30 | 109 | 60% |
| Hyperoxia sensing: From molecular mechanisms to significance in disease | 2010 | 32 | 181 | 34% |
| Pathways of cell signaling in hyperoxia | 2003 | 103 | 81 | 52% |
| MORPHOLOGICAL-CHANGES IN PULMONARY OXYGEN-TOXICITY | 1986 | 301 | 12 | 83% |
| Hyperoxia in the intensive care unit: why more is not always better | 2007 | 90 | 41 | 46% |
| Cytokines in tolerance to hyperoxia-induced injury in the developing and adult lung | 2006 | 54 | 112 | 38% |
| Superoxide dismutase and pulmonary oxygen toxicity | 1997 | 34 | 68 | 62% |
| Hyperoxia-induced signal transduction pathways in pulmonary epithelial cells | 2007 | 55 | 138 | 48% |
| The cellular basis for diverse responses to oxygen | 2007 | 134 | 130 | 23% |
| Pulmonary antioxidant defenses in the preterm newborn with respiratory distress and bronchopulmonary dysplasia in evolution: Implications for antioxidant therapy | 2004 | 50 | 122 | 36% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | WINTHROP UNIV HOSP | 5 | 22% | 1.8% | 21 |
| 2 | IMMUNOL BONE MARROW TRANSPLANT PROGRAM | 3 | 100% | 0.3% | 3 |
| 3 | HYPOX STATES | 1 | 38% | 0.3% | 3 |
| 4 | PEDIAT SURG PROGRAM | 1 | 40% | 0.2% | 2 |
| 5 | UNIT CHIETI | 1 | 40% | 0.2% | 2 |
| 6 | LUNG HEART | 1 | 33% | 0.2% | 2 |
| 7 | ACRON INT TECHNOL LTD | 1 | 50% | 0.1% | 1 |
| 8 | AUTOIMMUNE INFLAMMAT DIS | 1 | 50% | 0.1% | 1 |
| 9 | CALVIN FLAVIA OAK ASTHMA TREATMENT IL | 1 | 50% | 0.1% | 1 |
| 10 | MED UNIT HLTH ENVIRONM | 1 | 50% | 0.1% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000156334 | NON PROTEIN BOUND IRON//HUMAN NUTR SCI PAEDIAT//TOTAL HYDROPEROXIDE |
| 2 | 0.0000134842 | BRONCHOPULMONARY DYSPLASIA//CHRONIC LUNG DISEASE//ALVEOLARIZATION |
| 3 | 0.0000097035 | MEDTAYSIDE CHILD HLTH//CHEMIOXYEXCITATION//GLUTATHIONE DISEQUILIBRIUM |
| 4 | 0.0000090294 | SHOCK TRAUMA S//SURG ALPERT MED//A549 CELL APOPTOSIS |
| 5 | 0.0000084756 | LUNG LYMPH FISTULA//OXYGEN DERIVED METABOLITES//OXIDANT LUNG INJURY |
| 6 | 0.0000084649 | VENTURI MASK//INSPIRATORY OXYGEN FRACTION//CASPE |
| 7 | 0.0000084581 | ENDOGENOUS ANTIOXIDANT DEFENCE//MELON EXTRACT//ORGOTEIN |
| 8 | 0.0000082882 | LUNG METABOLIC FUNCTION//LUNG DRUG UPTAKE//PULMONARY CAPILLARY ENDOTHELIUM |
| 9 | 0.0000075093 | MNSOD//MANGANESE SUPEROXIDE DISMUTASE//SOD2 |
| 10 | 0.0000072083 | PHOSPHATIDYLCHOLINE SECRETION//PNEUMOCYTE TYPE II//METAL AEROSOL |